Shuttle Pharmaceuticals Holdings Inc (SHPH)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile

Shuttle Pharmaceuticals Holdings Inc

Healthcare (1200)

(240) 403-4212

401 PROFESSIONAL DRIVE, GAITHERSBURG

Prossima data di guadagno

Ultimi documenti SEC

SHPH's Discussions on Twitter

Confronta SHPH con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SHPH Shuttle Pharmaceuticals Holdings Inc	0.85	3.03M	0	-7.35M	-5.48M	-0.38
ZTS Zoetis Inc	176.74	80.59B	9.15B	2.43B	2.31B	4.92
HLN Haleon Plc Adr	9.72	44.17B	14.26B	1.55B	0	0.3327
TAK Takeda Pharmaceutical Co Adr	13.57	42.61B	30.27B	1.93B	3.45B	0.444
TEVA Teva Pharmaceutical Industries Ltd Adr	16.57	18.77B	16.77B	-959.00M	1.37B	-2.00
VTRS Viatris Inc	13.22	15.73B	15.05B	-883.30M	1.89B	1.53

Shuttle Pharmaceuticals Holdings Inc Borsa (SHPH) Ultime notizie

Shuttle Pharmaceuticals Holdings Inc Azioni (SHPH) Dati Finanziari

Shuttle Pharmaceuticals Holdings Inc (SHPH)

Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile

Confronta SHPH con altri titoli

Shuttle Pharmaceuticals Holdings Inc Borsa (SHPH) Ultime notizie

Shuttle Pharma Expands Patient Enrollment for Phase 2 - GlobeNewswire

Shuttle Pharmaceuticals stock hits 52-week low at $0.83 By Investing.com - Investing.com UK

Shuttle Pharmaceuticals Starts Phase 2 Trial for Glioblastoma - TipRanks

Shuttle Pharmaceuticals Launches Phase 2 Trial for Breakthrough Glioblastoma Treatment | SHPH Stock News - StockTitan

Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Up - GuruFocus.com

Micro Cap Company Is Soaring On Phase 2 Trial Update - MSN

500: Something went wrong - Investing.com UK

Shuttle Pharma Provides Third Quarter 2024 Corporate Update - GlobeNewswire

Shuttle Pharma Advances Phase 2 Trial, Secures $4.5M Funding for Cancer Treatment Study | SHPH Stock News - StockTitan

Shuttle Pharmaceuticals’ $4.5 Million Common Stock Offering - Global Legal Chronicle

Top 3 Penny Stocks to Watch Today – October 31, 2024 - The Global Domains News

Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination News - MSN

Shuttle Pharma Raises $4.5M for Clinical Trials - TipRanks

3 Penny Stocks to Watch Now, 10/31/24 - TipRanks

Shuttle Pharmaceuticals Successfully Doses First Patients in Phase 2 Clinical Trial for Glioblastoma Treatment - Defense World

Shuttle Pharma doses three subjects in Phase II glioblastoma treatment trial - Yahoo! Voices

"Stocks Key Trendlines: PRSO, PFIE, SHPH, BKYI, LIXT on the Verge of Breakthroughs" - Marketscreener.com

SHPHShuttle Pharmaceuticals Holdings, Inc. Latest Stock News & Market Updates - StockTitan

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of - GlobeNewswire

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - StockTitan

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - Benzinga

Shuttle Pharma Pays Off Senior Secured Convertible Note - GlobeNewswire

Micro Cap Soaring On Phase 2 Trial Update - Invezz

TSX American Preferred Stock Index (STNC) QuotePress Release - The Globe and Mail

US Stocks Mixed; McDonald's Posts Upbeat Earnings - Benzinga

Shuttle Pharmaceuticals Advances Phase 2 Glioblastoma Trial - TipRanks

Shuttle Pharma (SHPH) Stock Rises Pre-Market With Completion Site Enrollments - Stocks Telegraph

Shuttle Pharma Doses First Patients in Phase 2 Clinical - GlobeNewswire

Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma - Yahoo Finance

Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga

Shuttle Pharmaceuticals Shares Rise 63% on Drug-Study Site Update - MarketWatch

Shuttle Pharmaceuticals Advances Glioblastoma Clinical Trials - TipRanks

Shuttle Pharma Completes Clinical Trial Site Enrollment for - GlobeNewswire

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma - Marketscreener.com

Shuttle Pharmaceuticals to Present at ThinkEquity Conference - TipRanks

Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024 - GlobeNewswire

Shuttle Pharmaceuticals completes funding round, raises $790,000 By Investing.com - Investing.com Canada

Shuttle Pharmaceuticals completes funding round, raises $790,000 - Investing.com India

Shuttle Pharmaceuticals Holdings, Inc. announced that it expects to receive $1.3 million in funding - Marketscreener.com

Kingsoft Cloud Holdings Limited (NASDAQ:KC) Short Interest Update - Defense World

Office Properties Income Trust (NASDAQ:OPINL) Shares Up 3.9% – Here’s Why - Defense World

Munters Group AB (publ) (OTCMKTS:MMNNF) Stock Price Down 14.1% – Should You Sell? - Defense World

Shuttle Pharmaceuticals (NASDAQ:SHPH) Shares Up 7.2% – Should You Buy? - Defense World

Getlink: Shuttle Traffic in September 2024 - Yahoo Finance

SHPH stock touches 52-week low at $1.11 amid market challenges - Investing.com Australia

SHPH stock touches 52-week low at $1.11 amid market challenges By Investing.com - Investing.com South Africa

Stock Market Today: S&P 500 rides Nvidia-led tech surge to close higher - Investing.com

Union Pacific says FXE issuing some US-Mexico grain shuttle permits - Yahoo Finance

American Century Companies Inc. Lowers Stock Holdings in Paycom Software, Inc. (NYSE:PAYC) - Defense World

Ensign Peak Advisors Inc Sells 13,160 Shares of Owens Corning (NYSE:OC) - Defense World

Frank Rimerman Advisors LLC Takes $386,000 Position in Texas Roadhouse, Inc. (NASDAQ:TXRH) - Defense World

Shuttle Pharmaceuticals Holdings Inc Azioni (SHPH) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a SHPH